Company Long-Term Loans and Borrowings: cyclerion.com (CYCN)

Public company logo of cyclerion.com (CYCN)

This daily price chart for Cyclerion Therapeutics (CYCN) reflects the current 0.00. The issuer's stability is constrained by a narrow development pipeline and high research expenditures. Financial success is based on the creation of sGC stimulators for the therapy of cardiovascular and cerebral pathologies with the support of insurance companies. The firm's environmental profile is standard, consisting of compliance with biomaterial disposal regulations and basic energy saving in laboratories.

Cyclerion Therapeutics (CYCN) Company Long-Term Debts: for the period 07/04/2022 - 09/09/2026

Cyclerion Therapeutics, Inc. (CYCN) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Cyclerion Therapeutics Inc.|CYCN - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Cyclerion Therapeutics|CYCN - Total Company Value
- book capitalization information:
Net Asset Value per Share Cyclerion Therapeutics|CYCN - Book Capitalization|Market Cap to Net Assets Ratio cyclerion.com|CYCN - Cumulative Company Assets
- debt level and financial liquidity data:
Debt to Capital Cyclerion Therapeutics|CYCN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Cyclerion Therapeutics Inc.|CYCN - Company Debts|Debt to Book Capitalization Ratio Cyclerion Therapeutics|CYCN - Company Long-Term Debts|Short-Term Debt Cyclerion Therapeutics|Intermediate Coverage Ratio cyclerion.com
- earnings and market multiples details:
CYCN - Net Profit
Analysis of all company metrics:Cyclerion Therapeutics (CYCN)
Manufactured product of Cyclerion

Long-term debt aggregates all credit obligations with maturities exceeding twelve months, determining the stability of the capital structure. An increase in this metric signals either expansion or refinancing risk. Monitoring an organization's long-term financial debt allows for an assessment of its liquidity cushion. For Cyclerion Therapeutics (CYCN), this indicator reflects the cost of maintaining its R&D core. Debt stability confirms the company's ability to fund the work of neurobiologists without emergency share dilution.

Who Cyclerion Therapeutics competes with

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Liabilities vikingtherapeutics.com (VKTX)|Company Long-Term Liabilities SUPN (Supernus)|CPRX - Long-Term Debt|Company Long-Term Debts DNLI (Denali Therapeutics Inc)|HRMY - Company Long-Term Liabilities|BHVN - Company Long-Term Debt|AMLX: Company Long-Term Debt|TRVI: Company Long-Term Debts|Long-Term Debt Praxis Precision Medicines Inc (PRAX)|Company Long-Term Debt Anavex Corp|CBLL: Company Long-Term Loans and Borrowings|Company Long-Term Debts PRTA|Long-Term Debt Volume alector.com|Company Long-Term Debt Annexon ANNX|Omeros Corp (OMER) - Long-Term Debt|NGNE - Company Long-Term Debt|ACIU (AC Immune Inc) - Company Long-Term Indebtedness|VYGR (Voyager Therapeutics) - Company Long-Term Liabilities|neumoratx.com - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities SCLX|TVGN (Tevogen Bio Holdings Inc.) - Amount of Long-Term Liabilities|Company Long-Term Debts ACOG|CGTX (cogrx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts IKT (Inhibikase Therapeutics)|cassavasciences.com (SAVA) - Long-Term Debt|ASRT - Company Long-Term Debt|Company Long-Term Loans and Borrowings COYA (Coya Therapeutics, Inc.)|VTGN: Company Long-Term Debts|Ovid Therapeutics (OVID) - Company Long-Term Debts|Company Long-Term Debt Acumen Pharmaceuticals|cervomed.com - Long-Term Liabilities|Company Long-Term Debts ATHE|CLNN - Long-Term Debt|PepGen - Company Long-Term Liabilities|Company Long-Term Debts jupiterneurosciences.com JUNS|RLMD: Company Long-Term Liabilities|annovisbio.com - Amount of Long-Term Liabilities|GRCE: Company Long-Term Debts|AIFF - Long-Term Debt Volume|KLTO (ANEW Medical) - Company Long-Term Debts|Company Long-Term Liabilities NeuroSense Therapeutics, Ltd. (NRSN)|Company Long-Term Debt Reviva Pharmaceuticals (RVPH)|Long-Term Debt Volume metaviatx.com|Company Long-Term Debts NRXS (NeurAxis)|HSDT - Company Long-Term Liabilities|PASG: Company Long-Term Liabilities|Long-Term Debt Neuphoria Therapeutics Inc.|NERV: Company Long-Term Debts|Company Long-Term Liabilities athira.com|Company Long-Term Debt Addex Therapeutics Ltd|Company Long-Term Indebtedness ALZN (Alzamend)|Company Long-Term Debt Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Company Long-Term Indebtedness|Company Long-Term Debts CRGT (Cortigent)|avenuetx.com (ATXI) - Long-Term Debt|BCLI: Company Long-Term Liabilities|CARA - Company Long-Term Debts|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Eliem Therapeutics Inc. - Company Long-Term Loans and Borrowings|Company Long-Term Debt Intra-Cellular Therapies Inc.|Long-Term Debt longboardpharma.com LBPH|Company Long-Term Debts MRNS|Company Long-Term Liabilities NKGen Biotech Inc NKGN|NeuroBo - Company Long-Term Liabilities|Sage Therapeutics Inc (SAGE) - Long-Term Debt|Synaptogenix, Inc. - Company Long-Term Debts|trevena.com (TRVN) - Company Long-Term Liabilities|vigilneuro.com (VIGL) - Company Long-Term Debt|WENA (Anew Medical Inc.) - Company Long-Term Debt|CERE (Cerevel) - Company Long-Term Debts